|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2006-2-27
|
|
pubmed:abstractText |
Preclinical evaluation of neuroprotectants fostered high expectations of clinical efficacy. When not matched, the question arises whether experiments are poor indicators of clinical outcome or whether the best drugs were not taken forward to clinical trial. Therefore, we endeavored to contrast experimental efficacy and scope of testing of drugs used clinically and those tested only experimentally.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0364-5134
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
59
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
467-77
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16453316-Animals,
pubmed-meshheading:16453316-Disease Models, Animal,
pubmed-meshheading:16453316-Drug Evaluation, Preclinical,
pubmed-meshheading:16453316-Humans,
pubmed-meshheading:16453316-Meta-Analysis as Topic,
pubmed-meshheading:16453316-Models, Biological,
pubmed-meshheading:16453316-Neuroprotective Agents,
pubmed-meshheading:16453316-PubMed,
pubmed-meshheading:16453316-Research Design,
pubmed-meshheading:16453316-Stroke,
pubmed-meshheading:16453316-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
1,026 experimental treatments in acute stroke.
|
|
pubmed:affiliation |
Neuroscience Lab, Department of Medicine, University of Melbourne, Austin Health, Heidelberg, VIC 3084, Australia.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|
